All In Biotech

Drug Trial Radar · NCT03013543

Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity

Setmelanotide (RM-493) Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity

Last checked: Nov 19, 2026Latest source record: Aug 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

213

Actual

Start

Feb 10, 2017

Primary completion

Mar 1, 2022

Study completion Mar 1, 2022

Sponsor

Lead sponsor
Rhythm Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Jan 6, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 6 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study was to determine the effect of setmelanotide (RM-493) on weight, hunger assessments, and other factors in participants with rare genetic disorders of obesity.

Conditions

  • Genetic Obesity
  • Obesity
  • Obesity Due to Melanocortin 4 Receptor Deficiency

Interventions

  • SetmelanotideDrug

    RM-493 QD SC injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With ≥ 5% Reduction in Body Weight From Baseline After 3 Months of Setmelanotide TreatmentTime frame: Baseline to Month 3

Locations

58 sites in 9 countries. Site status is shown where the registry gives one.

  • Synexus Clinical Research US, Inc. - Simon Williamson Clinic, PC

    Birmingham, Alabama

  • Synexus Clinical Research US, Inc. - Phoenix Southeast

    Chandler, Arizona

  • Synexus Clinical Research US, Inc. - Central Arizona Medical Associates, PC

    Mesa, Arizona

  • Honor Health Research Institute

    Scottsdale, Arizona

  • Axis Clinical Trials-Downtown

    Los Angeles, California

  • Axis Clinical Trials Headquarters

    Los Angeles, California

  • San Diego Wake Research

    San Diego, California

  • Anschutz Health and Wellness Center University of Colorado Anschutz Medical Campus

    Aurora, Colorado

  • Division of Endocrinology and Diabetes Children's National Hospital

    Washington D.C., District of Columbia

  • University of Florida College of Medicine

    Gainesville, Florida

  • AXIS South Florida Clinical Trials

    Hialeah, Florida

  • Florida Hospital

    Orlando, Florida

  • Synexus Clinical Research US, Inc. - St. Petersburg

    Pinellas Park, Florida

  • Synexus Clinical Research US, Inc. - Chicago

    Chicago, Illinois

  • Maine Medical Partners

    Portland, Maine

  • NIH Hatfield Clinical Research Center

    Bethesda, Maryland

  • Baystate Medical Center

    Springfield, Massachusetts

  • University of Michigan Medicine

    Ann Arbor, Michigan

  • Precision Medicine for Obesity Research: Gastroenterology & Hepatology Mayo Clinic

    Rochester, Minnesota

  • Washington University St. Louis

    St Louis, Missouri

  • Impact Clinical Trials

    Las Vegas, Nevada

  • AXIS New York Clinical Trials

    Brooklyn, New York

  • University at Buffalo

    Buffalo, New York

  • AXIS Clinical Trials

    New York, New York

  • Icahn School of Medicine at Mount Sinai

    New York, New York

  • Columbia University

    New York, New York

  • Duke University Medical Center

    Durham, North Carolina

  • Wake Research Inc.

    Raleigh, North Carolina

  • Synexus Clinical Research US, Inc. - Akron

    Akron, Ohio

  • Synexus Clinical Research US, Inc. - Cincinnati

    Cincinnati, Ohio

  • Synexus Clinical Research US, Inc. - Columbus

    Columbus, Ohio

  • Obesity Institute, Geisinger Clinic

    Danville, Pennsylvania

  • Childrens Hospital of Philadelphia

    Philadelphia, Pennsylvania

  • Synexus Clinical Research US, Inc. - Primary Care Associates, PC

    Anderson, South Carolina

  • Wake Research TN

    Chattanooga, Tennessee

  • Le Bonheur Children's Hospital

    Memphis, Tennessee

  • Vanderbilt University School of Medicine

    Nashville, Tennessee

  • Baylor College of Medicine

    Houston, Texas

  • Synexus Clinical Research US, Inc. - Plano

    Plano, Texas

  • Synexus Clinical Research US, Inc. - San Antonio

    San Antonio, Texas

Showing 40 of 58 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.